Oncology
 |
|
13 february 2019 10:00:19 |
| The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastoma (British Journal of Cancer) |
|
Tweet |
| 97 viewsCategory: Oncology |
 A multi-national, randomised, open-label, parallel, phase III non-inferiority study comparing NK105 and paclitaxel in metastatic or recurrent breast cancer patients (British Journal of Cancer)Prognostic impact of CD8 and programmed death-ligand 1 expression in patients with resectable non-small cell lung cancer (British Journal of Cancer) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
